Filing Flows › Neogen (NEOG) › Q4 FY26 › vs Q3 FY26
Neogen (NEOG) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Neogen's revenue rose $14.1M (+7%) from $211M in Q3 FY26 to $225M in Q4 FY26. The biggest changes: Product +$12.6M (+7%); Service +$1.5M (+6%).
Neogen, Q4 FY26: revenue $225M (-0.1% year over year), operating margin 1.4%, net loss $11.3M, operating cash flow $30.2M. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Product | $199M | $186M | $12.6M | +7% |
| Service | $26.5M | $25.0M | $1.5M | +6% |
| Revenue | $225M | $211M | $14.1M | +7% |
| Income tax benefit | $800K | $3.3M | −$2.5M | -76% |
| Net loss | $11.3M | $17.0M | −$5.7M | -34% |
| Costs & expenses | $237M | $232M | $5.9M | +3% |
| Operating costs | $222M | $214M | $7.7M | +4% |
| Interest & other, net | $15.2M | $17.0M | −$1.8M | -11% |
| Cost of revenue | $118M | $112M | $5.3M | +5% |
| Research & development | $4.9M | $3.8M | $1.1M | +29% |
| Sales & marketing | $41.1M | $38.2M | $2.9M | +8% |
| General & admin | $58.7M | $60.3M | −$1.6M | -3% |
| Operating cash sources | $41.5M | $39.7M | $1.8M | +5% |
| Depreciation & amortization | $29.4M | $28.9M | $482K | +2% |
| Share-based compensation | $3.0M | $1.1M | $1.9M | +173% |
| Working capital & other | $9.1M | $9.7M | −$585K | -6% |
| Net loss absorbed | $11.3M | $17.0M | −$5.7M | -34% |
| Operating cash flow | $30.2M | $22.7M | $7.5M | +33% |
Questions
How much did Neogen's revenue grow quarter over quarter in Q4 FY26?
Neogen's revenue rose $14.1M (+7%) from $211M in Q3 FY26 to $225M in Q4 FY26.
What drove Neogen's revenue change in Q4 FY26?
Product +$12.6M (+7%); Service +$1.5M (+6%).